Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes-Reference-Cited by-同舟云学术

Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes

Published:2012-12-14 Issue:1 Volume:75 Page:146-161
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Samtani Mahesh N.,Raghavan Nandini,Shi Yingqi,Novak Gerald,Farnum Michael,Lobanov Victor,Schultz Tim,Yang Eric,DiBernardo Allitia,Narayan Vaibhav A.,

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2012.04308.x/fullpdf

Reference50 articles.

1. Mild cognitive impairment clinical trials;Petersen;Nat Rev Drug Discov,2003

2. Mild cognitive impairment: ten years later;Petersen;Arch Neurol,2009

3. International Psychogeriatric Association Expert Conference on mild cognitive impairment. Mild cognitive impairment;Gauthier;Lancet,2006

4. Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions;Brooks;Alzheimers Res Ther,2010

5. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people;De Meyer;Arch Neurol,2010

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Data-driven modelling of neurodegenerative disease progression: thinking outside the black box;Nature Reviews Neuroscience;2024-01-08

2. Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB;CPT: Pharmacometrics & Systems Pharmacology;2023-05-02

3. Pharmacometric modeling of drug adverse effects: an application of mixture models in schizophrenia spectrum disorder patients treated with clozapine;Journal of Pharmacokinetics and Pharmacodynamics;2022-11-15

4. Prediction of Alzheimer’s Disease Progression Based on Magnetic Resonance Imaging;ACS Chemical Neuroscience;2021-11-01

5. Modelling Decline in Cognition to Decline in Function in Alzheimer’s Disease;Current Alzheimer Research;2020-11-16